Search Within

Hira Abbas Rizvi

  1. "Journal of Clinical Oncology"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (6)
Groups
  1. Department of Medicine (35)
  2. Solid Tumor Oncology Division (35)
  3. Thoracic Oncology (35)
  4. Weinberg Fellows (21)
  5. Department of Pathology and Laboratory Medicine (18)
  6. GSK Faculty (18)

More Groups

People
  1. Matthew Hellmann (30)
  2. Andrew Plodkowski (15)
  3. Gregory Riely (13)
  4. Kathryn Arbour (12)
  5. Mark Kris (12)
  6. Charles Rudin (10)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (6)
  4. 2020 (8)
  5. 2019 (7)
  6. 2018 (9)

More Years

Publications
  1. Journal of Clinical Oncology (35)
Publishers
  1. American Society of Clinical Oncology (35)

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer
    Journal Article

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Martínez-Bernal, G.; Ferrara, R.; Lai, W. V.; Hendriks, L. E. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety of programmed death-1 pathway inhibitors among patients with non-small-cell lung cancer and preexisting autoimmune disorders
    Journal Article

    Leonardi, G. C.; Gainor, J. F.; Altan, M.; Kravets, S.; Dahlberg, S. E.; Gedmintas, L.; Azimi, R.; Rizvi, H.; Riess, J. W.; Hellmann, M. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders
    Meeting Abstract

    Leonardi, G. C.; Gainor, J. F.; Azimi, R. S.; Riess, J.; Rizvi, H.; Hellmann, M. D.; Awad, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy
    Journal Article

    Naidoo, J.; Wang, X.; Woo, K. M.; Iyriboz, T.; Halpenny, D.; Cunningham, J.; Chaft, J. E.; Segal, N. H.; Callahan, M. K.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save